Skip to search formSkip to main contentSkip to account menu

Pentavalent KLH Conjugate Vaccine

A pentavalent vaccine comprised of the epitope antigens of the ganglioside lactones GD2L and GD3L, Globo H hexasaccharide 1 (Globo H), fucosyl GM1… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
An in silico functional annotation and screening of potential drug targets derived from Leishmania spp. hypothetical proteins identified by immunoproteomics.
2011
2011
Cutaneous sporotrichoid leishmaniasis resistant to pentavalent antimonial therapy: complete resolution with itraconazole
Sporotrichoid leishmaniasis is a sporadic form of cutaneous leishmaniasis, a protozoal infection, reported particularly in the… 
2008
2008
[Effect of a hydrophilic formulation of topical paromomycin on cutaneous leishmaniasis among patients with contraindications for treatment with pentavalent antimonials].
The therapeutic effect of and adverse events associated with topical use of 10% paromomycin gel on cutaneous leishmaniasis are… 
2000
2000
Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials.
Visceral leishmaniasis should be suspected in renal transplant recipients in whom a fever develops of unknown origin. A 53-year… 
1998
1998
[A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial].
The authors report a case of a 89 years-old woman with mucocutaneous leishmaniasis and previous diabetes mellitus and high blood… 
1994
1994
Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
1990
1990
Immunopathology of American cutaneous leishmaniasis. Modulation of MHC class II gene products by keratinocytes before and after glucantime therapy.
Epidermal changes from 32 cutaneous and 3 mucosal American cutaneous leishmaniasis (ACL) active lesions were studied for HLA-DR… 
1990
1990
Severe arthralgia, not related to dose, associated with pentavalent antimonial therapy for mucosal leishmaniasis.
1989
1989
Evaluation ofNeutralizing Antibodies toTypeA,B,E,andF Botulinum Toxins inSerafromHumanRecipients ofBotulinum Pentavalent (ABCDE)Toxoid
1985
1985
PENTAVALENT ANTIMONIAL TREATMENT IN MUCOSAL LEISHMANIASIS
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)